Sign Up to like & get
recommendations!
1
Published in 2020 at "Clinical Trials"
DOI: 10.1158/1538-7445.am2020-5386
Abstract: Objective: Recent clinical trials considered Claudin18 splice variants 2 (CLDN18.2) as the promising potential target for gastrointestinal(GI) cancer treatment. CLDN18.2 specifically express in normal stomach and gastric cancer, while ectopic activation can also be found…
read more here.
Keywords:
cldn18 rna;
cldn18;
cancer;
ctcs ... See more keywords